prikaz prve stranice dokumenta Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity
No public access
Scientific paper - Original scientific paper
Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity
Rheumatology International, 43 (2023), 11; 2073-2079. https://doi.org/10.1007/s00296-023-05391-6


Cite this document

Šegota, A., Schnurrer Luke Vrbanić, T., Avancini Dobrović, V. & Mirić, F. (2023). Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity. Rheumatology International, 43. (11), 2073-2079. doi: 10.1007/s00296-023-05391-6

Šegota, Adelmo, et al. "Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity." Rheumatology International, vol. 43, no. 11, 2023, pp. 2073-2079. https://doi.org/10.1007/s00296-023-05391-6

Šegota, Adelmo, Tea Schnurrer Luke Vrbanić, Viviana Avancini Dobrović and Filip Mirić. "Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity." Rheumatology International 43, no. 11 (2023): 2073-2079. https://doi.org/10.1007/s00296-023-05391-6

Šegota, A., et al. (2023) 'Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity', Rheumatology International, 43(11), pp. 2073-2079. doi: 10.1007/s00296-023-05391-6

Šegota A, Schnurrer Luke Vrbanić T, Avancini Dobrović V, Mirić F. Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity. Rheumatology International [Internet]. 2023 July 14 [cited 2024 May 08];43(11):2073-2079. doi: 10.1007/s00296-023-05391-6

A. Šegota, T. Schnurrer Luke Vrbanić, V. Avancini Dobrović and F. Mirić, "Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity", Rheumatology International, vol. 43, no. 11, pp. 2073-2079, July 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:632052. [Accessed: 08 May 2024]